Costs of autologous and allogeneic hematopoietic cell transplantation in the United States: A study using a large National Private Claims Database

Bone Marrow Transplantation

Volumn 48, Issue 2, 2013, Pages 294-300

  Majhail, N S ^a,b   Mau, L W ^c   Denzen, E M ^b   Arneson, T J ^c  

^a CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH   (United States)

^b NATIONAL MARROW DONOR PROGRAM   (United States)

^c MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

allogeneic; autologous; costs; hematopoietic cell transplantation; hospitalization

Indexed keywords

ADULT; AGE DISTRIBUTION; ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION; CELL TRANSPLANTATION; COHORT ANALYSIS; FEMALE; HEALTH CARE COST; HEALTH ECONOMICS; HEALTH INSURANCE; HOSPITALIZATION COST; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALIZATION; HUMANS; INFANT; INSURANCE, HEALTH; MIDDLE AGED; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84873424104     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2012.133     Document Type: Article

References (17)

1. Stranges E, Russo CA, Friedman B. Procedures with the most rapidly increasing hospital costs, 2004-2007. HCUP Statistical Brief #82. December 2009. Agency for Healthcare Research and Quality: Rockville, MD. http://www.hcup-us. ahrq.gov/ reports/statbriefs/sb82.pdf
2. Majhail NS, Mothukuri JM, Brunstein CG, Weisdorf DJ. Costs of hematopoietic cell transplantation: Comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications. Biol Blood Marrow Transplant 2009; 15: 564-573
3. Majhail NS, Mothukuri JM, Macmillan ML, Verneris MR, Orchard PJ, Wagner JE et al. Costs of pediatric allogeneic hematopoietic-cell transplantation. Pediatr Blood Cancer 2010; 54: 138-143
4. Lee SJ, Anasetti C, Kuntz KM, Patten J, Antin JH, Weeks JC. The costs and costeffectiveness of unrelated donor bone marrow transplantation for chronic phase chronic myelogenous leukemia. Blood 1998; 92: 4047-4052
5. Lee SJ, Klar N, Weeks JC, Antin JH. Predicting costs of stem-cell transplantation. J Clin Oncol 2000; 18: 64-71
6. Saito AM, Cutler C, Zahrieh D, Soiffer RJ, Ho VT, Alyea EP et al. Costs of allogeneic hematopoietic cell transplantation with high-dose regimens. Biol Blood Marrow Transplant 2008; 14: 197-207
7. Saito AM, Zahrieh D, Cutler C, Ho VT, Antin JH, Soiffer RJ et al. Lower costs associated with hematopoietic cell transplantation using reduced intensity vs high-dose regimens for hematological malignancy. Bone Marrow Transplant 2007; 40: 209-217
8. Bennett C, Waters T, Stinson T, Almagor O, Pavletic Z, Tarantolo S et al. Valuing clinical strategies early in development: A cost analysis of allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 1999; 24: 555-560
9. Rizzo JD, Vogelsang GB, Krumm S, Frink B, Mock V, Bass EB. Outpatient-based bone marrow transplantation for hematologic malignancies: Cost saving or cost shifting? J Clin Oncol 1999; 17: 2811-2818
10. Lee SJ, Astigarraga CC, Eapen M, Artz AS, Davies SM, Champlin R et al. Variation in supportive care practices in hematopoietic cell transplantation. Biol Blood Marrow Transplant 2008; 14: 1231-1238
11. Lee SJ, Joffe S, Artz AS, Champlin RE, Davies SM, Jagasia M et al. Individual physician practice variation in hematopoietic cell transplantation. J Clin Oncol 2008; 26: 2162-2170
12. Majhail NS, Murphy EA, Omondi NA, Majhail NS, Murphy EA, Omondi NA et al. Allogeneic transplant physician and center capacity in the United States. Biol Blood Marrow Transplant 2011; 17: 956-961
13. Iezzoni LI. Assessing quality using administrative data. Ann Intern Med 1997; 127: 666-674
14. Riley GF. Administrative and claims records as sources of health care cost data. Med Care 2009; 47: S51-S55
15. Etzioni R, Riley GF, Ramsey SD, Brown M. Measuring costs: Administrative claims data, clinical trials, and beyond. Med Care. 2002; 40: III63-III72
16. Jones JA, Qazilbash MH, Shih YC, Cantor SB, Cooksley CD, Elting LS. In-hospital complications of autologous hematopoietic stem cell transplantation for lymphoid malignancies: Clinical and economic outcomes from the Nationwide Inpatient Sample. Cancer 2008; 112: 1096-1105
17. McClune BL, Weisdorf DJ, Pedersen TL, Tunes da Silva G, Tallman MS, Sierra J et al. Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome. J Clin Oncol 2010; 28: 1878-1887